These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 25149531
1. Tuberin-deficiency downregulates N-cadherin and upregulates vimentin in kidney tumor of TSC patients. Liang S, Salas T, Gencaslan E, Li B, Habib SL. Oncotarget; 2014 Aug 30; 5(16):6936-46. PubMed ID: 25149531 [Abstract] [Full Text] [Related]
3. Novel mechanism of regulation of fibrosis in kidney tumor with tuberous sclerosis. Liang S, Cuevas G, Tizani S, Salas T, Liu H, Li B, Habib SL. Mol Cancer; 2013 May 25; 12():49. PubMed ID: 23705901 [Abstract] [Full Text] [Related]
4. Insight into mechanism of oxidative DNA damage in angiomyolipomas from TSC patients. Habib SL. Mol Cancer; 2009 Mar 05; 8():13. PubMed ID: 19265534 [Abstract] [Full Text] [Related]
6. Hyperactivation of Akt/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes. Habib SL, Liang S. Oncotarget; 2014 May 15; 5(9):2542-50. PubMed ID: 24797175 [Abstract] [Full Text] [Related]
9. Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma. El-Hashemite N, Zhang H, Henske EP, Kwiatkowski DJ. Lancet; 2003 Apr 19; 361(9366):1348-9. PubMed ID: 12711473 [Abstract] [Full Text] [Related]
10. Renal tumours in a Tsc2(+/-) mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin. Yang J, Kalogerou M, Samsel PA, Zhang Y, Griffiths DF, Gallacher J, Sampson JR, Shen MH. Oncogene; 2015 Feb 12; 34(7):922-31. PubMed ID: 24632604 [Abstract] [Full Text] [Related]
11. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Kenerson H, Folpe AL, Takayama TK, Yeung RS. Hum Pathol; 2007 Sep 12; 38(9):1361-71. PubMed ID: 17521703 [Abstract] [Full Text] [Related]
12. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY, Hsu SC, Lee HS, Lin SH, Tsai CS, Huang SM, Shih CC, Hsu YJ. J Vasc Surg; 2013 Feb 12; 57(2):475-85. PubMed ID: 23265586 [Abstract] [Full Text] [Related]
13. TSC2 deficiency increases PTEN via HIF1alpha. Mahimainathan L, Ghosh-Choudhury N, Venkatesan B, Das F, Mandal CC, Dey N, Habib SL, Kasinath BS, Abboud HE, Ghosh Choudhury G. J Biol Chem; 2009 Oct 09; 284(41):27790-27798. PubMed ID: 19648120 [Abstract] [Full Text] [Related]
14. Nox4 is a Target for Tuberin Deficiency Syndrome. Shi Q, Viswanadhapalli S, Friedrichs WE, Velagapudi C, Szyndralewiez C, Bansal S, Bhat MA, Choudhury GG, Abboud HE. Sci Rep; 2018 Feb 28; 8(1):3781. PubMed ID: 29491408 [Abstract] [Full Text] [Related]
19. Inhibition of mTORC1 induces loss of E-cadherin through AKT/GSK-3β signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells. Kim EY, Kim A, Kim SK, Kim HJ, Chang J, Ahn CM, Chang YS. Respir Res; 2014 Feb 26; 15(1):26. PubMed ID: 24571487 [Abstract] [Full Text] [Related]
20. Tuberous sclerosis complex: Hamartin and tuberin expression in renal cysts and its discordant expression in renal neoplasms. Bonsib SM, Boils C, Gokden N, Grignon D, Gu X, Higgins JP, Leroy X, McKenney JK, Nasr SH, Phillips C, Sangoi AR, Wilson J, Zhang PL. Pathol Res Pract; 2016 Nov 26; 212(11):972-979. PubMed ID: 27640314 [Abstract] [Full Text] [Related] Page: [Next] [New Search]